相关实验视频
Updated: Jul 13, 2025
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.6K
在当前的时代,TP53突变预测了新诊断的侵袭性B细胞淋巴瘤患者的不良结果
Daniel J Landsburg1, Jennifer Jd Morrissette2, Sunita D Nasta1
1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Blood advances
|October 18, 2023
概括
在扩散性大B细胞淋巴瘤 (DLBCL) 中的TP53突变预示着不良结果. 临床实验室突变分析 (CLMA) 可以识别这些突变,帮助DLBCL和高级B细胞淋巴瘤 (HGBL) 患者的预后和治疗决策.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 和高度B细胞淋巴瘤 (HGBL) 是一种具有攻击性的血液性恶性瘤.
- 基因组分析已经确定了子组,但临床适用性仍然有限.
- 预测性生物标志物对于个性化治疗策略至关重要.
研究的目的:
- 评估通过临床实验室突变分析 (CLMA) 检测到的突变在预测新诊断的DLBCL/HGBL患者的结果中的临床实用性.
- 评估特定突变与治疗反应,无进展生存率 (PFS) 和总生存率 (OS) 之间的相关性.
主要方法:
- 在2018-2022年间诊断的117名DLBCL/HGBL患者进行了回顾性分析,他们接受了CLMA.
- 患者接受了标准免疫化学疗法 (R-CHOP或R-EPOCH).
- 评估的结果包括整体反应率 (ORR),完整反应率 (CRR),PFS和OS.
主要成果:
- 在96%的样本中,CLMA成功地发现了突变,中位数是17天的周转时间.
- 在36%的瘤中发现的TP53突变与较低的ORR,CRR,2年PFS和2年OS有显著的关联.
- TP53功能丧失突变进一步与较差的结果相关,特别是在高风险患者中.
结论:
- 通过CLMA检测到的TP53突变是新诊断的DLBCL/HGBL中劣质结局的显著预测因素.
- CLMA 提供实时可操作的预后信息.
- 这项分析支持使用CLMA结果进行预后,并确定用于临床试验的患者.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K